(Q42699501)

5 November 2017

0 references

PEG-ing down (and preventing?) the cause of pegloticase failure (English)

1 reference

5 November 2017

Aryeh M Abeles

1

1 reference

5 November 2017

30 May 2014

1 reference

Arthritis Research and Therapy

5 November 2017

1 reference

5 November 2017

16

1 reference

5 November 2017

3

1 reference

5 November 2017

112

1 reference

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060209

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060209

The immunogenicity of polyethylene glycol: facts and fiction

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060209

Prevalence of contraindications and prescription of pharmacologic therapies for gout

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060209

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060209

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25142440

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25142440

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/AR4572

1 reference

PMC publication ID

4060209

Dimensions Publication ID

5 November 2017

0 references

1 reference

PMC publication ID

4060209

5 November 2017

PubMed publication ID

25142440

1 reference

PMC publication ID

4060209